title: Immunoscintigraphy with 111In-satumomab pendetide in patients with colorectal adenocarcinoma: performance and impact on clinical management.
abstract: OBJECTIVE
  The role of immunoscintigraphy with 111In-satumomab pendetide in the medical and/or surgical management of colorectal cancer patients was evaluated in a multicenter trial.
  
  
  METHODS
  This 103 patient study population included 46 individuals with rising serum carcinoembryonic antigen levels and otherwise negative diagnostic evaluation, 29 patients with known recurrence, presumed to be isolated and resectable, and 28 patients for whom standard diagnostic tests provided equivocal information.
  
  
  RESULTS
  No adverse reactions were noted following intravenous administration of 1 mg of satumomab pendetide radiolabeled with approximately 5 mCi of 111In. Thirty percent of patients developed human anti-mouse antibodies postinfusion. In the 84 patients for whom correlation with histopathologic, diagnostic, and/or clinical findings was available, antibody imaging demonstrated a sensitivity of 73 percent in patients with confirmed tumor (36/49) and negative results for all 35 patients with no evidence of malignancy. Occult disease was detected in 18 patients.
  
  
  CONCLUSIONS
  111In-satumomab pendetide immunoscintigraphy was helpful in the medical and/or surgical management of 45 (44 percent) patients and provided information unavailable from other diagnostic modalities.
authors.affiliation: Sansum Medical Clinic, Santa Barbara, California 93102-1239.
authors.forename: M L
authors.initials: ML
authors.lastname: Corman
authors.forename: S
authors.initials: S
authors.lastname: Galandiuk
authors.forename: G E
authors.initials: GE
authors.lastname: Block
authors.forename: E D
authors.initials: ED
authors.lastname: Prager
authors.forename: G J
authors.initials: GJ
authors.lastname: Weiner
authors.forename: D
authors.initials: D
authors.lastname: Kahn
authors.forename: H
authors.initials: H
authors.lastname: Abdel-Nabi
authors.forename: E P
authors.initials: EP
authors.lastname: Mitchell
authors.forename: V L
authors.initials: VL
authors.lastname: Pascucci
authors.forename: A N
authors.initials: AN
authors.lastname: Maroli
mesh_terms: D000230:Adenocarcinoma / Q000000981:diagnostic imaging* / Q000276:immunology; D000328:Adult; D000818:Animals; D000911:Antibodies, Monoclonal; D002272:Carcinoembryonic Antigen / Q000097:blood; D015179:Colorectal Neoplasms / Q000000981:diagnostic imaging* / Q000276:immunology; D005260:Female; D006801:Humans; D000922:Immunotoxins; D007205:Indium Radioisotopes; D008297:Male; D051379:Mice / Q000276:immunology; D009842:Oligopeptides; D004369:Pentetic Acid / Q000031:analogs & derivatives*; D012680:Sensitivity and Specificity; D015899:Tomography, Emission-Computed, Single-Photon
chemical_list: D000911:Antibodies, Monoclonal; D002272:Carcinoembryonic Antigen; D000922:Immunotoxins; C063430:Indium 111In-satumomab pendetide; D007205:Indium Radioisotopes; D009842:Oligopeptides; D004369:Pentetic Acid